{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:57:56Z","timestamp":1791068276161,"version":"4.1.0"},"reference-count":48,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,1,12]],"date-time":"2009-01-12T00:00:00Z","timestamp":1231718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:p><jats:bold>Objective:\u2002<\/jats:bold> To provide an overview for practicing clinicians on the pharmacological basis of cardiometabolic risk induced by antipsychotic drugs in patients with serious mental illness, to propose hypotheses to explain these risks and to give tips for managing cardiometabolic risk during antipsychotic treatment.<\/jats:p><jats:p><jats:bold>Method:\u2002<\/jats:bold> A MEDLINE search using terms for <jats:italic>atypical antipsychotics<\/jats:italic> (including individual drug names), <jats:italic>metabolic<\/jats:italic>, <jats:italic>cardiovascular<\/jats:italic>, <jats:italic>weight gain and insulin resistance<\/jats:italic>, cross\u2010referenced with <jats:italic>schizophrenia<\/jats:italic> was performed on articles published between 1990 and May 2008.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Strong evidence exists for significant cardiometabolic risk differences among several antipsychotic agents. Histamine H1 and serotonin 5HT2C antagonism are associated with risk of weight gain, but receptor targets for dyslipidemia and insulin resistance have not yet been identified. Convincing data indicate that hypertriglyceridemia and insulin resistance may occur in the absence of weight gain with certain antipsychotics.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Although lifestyle and genetics may contribute independent risks of cardiometabolic dysfunction in schizophrenia and other serious mental illness, antipsychotic treatment also represents an important contributor to risk of cardiometabolic dysfunction, particularly for certain drugs and for vulnerable patients. Mental health professionals must learn to recognize the clinical signposts indicating antipsychotic\u2010related cardiometabolic problems to forestall progression to type II diabetes, cardiovascular events and premature death.<\/jats:p>","DOI":"10.1111\/j.1600-0447.2008.01334.x","type":"journal-article","created":{"date-parts":[[2009,1,12]],"date-time":"2009-01-12T09:00:22Z","timestamp":1231750822000},"page":"171-179","source":"Crossref","is-referenced-by-count":209,"title":["Which comes first: atypical antipsychotic treatment or cardiometabolic risk?"],"prefix":"10.1111","volume":"119","author":[{"given":"S. M.","family":"Stahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,27]]},"reference":[{"key":"e_1_2_12_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31802e5126"},{"key":"e_1_2_12_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318166c4f7"},{"key":"e_1_2_12_4_2","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychoitc\u2010induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison DB","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_12_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.10.022"},{"key":"e_1_2_12_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/10401230490453293"},{"key":"e_1_2_12_7_2","volume-title":"Stahl\u2019s Essential Psychopharmacology","author":"Stahl SM","year":"2008"},{"key":"e_1_2_12_8_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.10.1821"},{"key":"e_1_2_12_9_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2006.0037"},{"key":"e_1_2_12_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2008.01317.x"},{"key":"e_1_2_12_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.13.1549"},{"key":"e_1_2_12_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.2.242"},{"key":"e_1_2_12_13_2","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.7.6.863"},{"key":"e_1_2_12_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881105058380"},{"key":"e_1_2_12_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.6.679"},{"key":"e_1_2_12_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.10.1123"},{"key":"e_1_2_12_17_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.45.5.633"},{"key":"e_1_2_12_18_2","first-page":"A42","article-title":"Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states","volume":"3","author":"Colton CW","year":"2006","journal-title":"Prev Chronic Dis"},{"key":"e_1_2_12_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000237947.80764.d9"},{"key":"e_1_2_12_20_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.10.1697"},{"key":"e_1_2_12_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj289"},{"key":"e_1_2_12_22_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.7.1273"},{"key":"e_1_2_12_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000219916.88810.1c"},{"key":"e_1_2_12_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.12.476"},{"key":"e_1_2_12_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.12.487"},{"issue":"9","key":"e_1_2_12_26_2","first-page":"1","article-title":"Dosing atypical antipsychotics","volume":"13","author":"Cutler AC","year":"2008","journal-title":"CNS Spectr"},{"key":"e_1_2_12_27_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0901"},{"key":"e_1_2_12_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2005.03.019"},{"key":"e_1_2_12_29_2","doi-asserted-by":"publisher","DOI":"10.1358\/mf.2005.27.5.908643"},{"key":"e_1_2_12_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4002066"},{"key":"e_1_2_12_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300027"},{"key":"e_1_2_12_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0611417104"},{"key":"e_1_2_12_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/374542a0"},{"key":"e_1_2_12_34_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145708008468"},{"key":"e_1_2_12_35_2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1176\/ajp.2006.163.7.1276","article-title":"Association of initial antipsychotic response to clozapine and long\u2010term weight gain","volume":"163","author":"Bai YM","year":"2006","journal-title":"Am J Psychiatry"},{"key":"e_1_2_12_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301209"},{"key":"e_1_2_12_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301142"},{"key":"e_1_2_12_38_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0516"},{"key":"e_1_2_12_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2008.01712.x"},{"key":"e_1_2_12_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200108000-00003"},{"key":"e_1_2_12_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301482"},{"key":"e_1_2_12_42_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10401230209147399","article-title":"Phenomenology of and risk factors for new\u2010onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases","volume":"14","author":"Jin H","year":"2002","journal-title":"Ann Clin Psychiatry"},{"issue":"1","key":"e_1_2_12_43_2","first-page":"100","article-title":"Diabetic ketoacidosis and hyperosmolar hyperglycemic state","volume":"101","author":"Gouni\u2010Berthold I","year":"2006","journal-title":"Med Klin (Munich)"},{"key":"e_1_2_12_44_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.5.1552"},{"key":"e_1_2_12_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000239789.83707.7d"},{"key":"e_1_2_12_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2006.04.009"},{"key":"e_1_2_12_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2007.00781.x"},{"key":"e_1_2_12_48_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1006"},{"key":"e_1_2_12_49_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0219"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.2008.01334.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.2008.01334.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T17:59:05Z","timestamp":1697392745000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.2008.01334.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,27]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1600-0447.2008.01334.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.2008.01334.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,27]]}}}